Cargando…

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study

BACKGROUND: Tuberculosis (TB) is preventable and curable but eliminating it has proven challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are essential for achieving TB elimination. We assessed future costs, cost-savings, and cost-effectiveness of introducing novel TB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Portnoy, Allison, Clark, Rebecca A., Quaife, Matthew, Weerasuriya, Chathika K., Mukandavire, Christinah, Bakker, Roel, Deol, Arminder K., Malhotra, Shelly, Gebreselassie, Nebiat, Zignol, Matteo, Sim, So Yoon, Hutubessy, Raymond C. W., Baena, Inés Garcia, Nishikiori, Nobuyuki, Jit, Mark, White, Richard G., Menzies, Nicolas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873163/ https://www.ncbi.nlm.nih.gov/pubmed/36693081 http://dx.doi.org/10.1371/journal.pmed.1004155

Ejemplares similares

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
por: Portnoy, Allison, et al.
Publicado: (2023)

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01(E) and BCG-revaccination
por: Clark, Rebecca A, et al.
Publicado: (2023)

New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01(E) and BCG-revaccination
por: Clark, Rebecca A., et al.
Publicado: (2023)

Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis
por: Portnoy, Allison, et al.
Publicado: (2023)

Cost-effectiveness of routine adolescent vaccination with an M72/AS01(E)-like tuberculosis vaccine in South Africa and India
por: Harris, Rebecca C., et al.
Publicado: (2022)

The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Hospitalization and Home-Based Care Strategies for People Living with HIV/AIDS: The Case of Zimbabwe
por: Hove-Musekwa, Senelani D., et al.
Publicado: (2014)

Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis
por: Jayawardana, Sahan, et al.
Publicado: (2022)

Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review
por: Bozzani, Fiammetta M., et al.
Publicado: (2022)

Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis
por: Weerasuriya, Chathika Krishan, et al.
Publicado: (2021)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
por: Weerasuriya, Chathika K, et al.
Publicado: (2021)

Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
por: Weerasuriya, Chathika K., et al.
Publicado: (2022)

An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England
por: Turner, Katherine M E, et al.
Publicado: (2013)

A review of the costs of delivering maternal immunisation during pregnancy
por: Procter, Simon R, et al.
Publicado: (2020)

What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2021)

Programme costs in the economic evaluation of health interventions
por: Johns, Benjamin, et al.
Publicado: (2003)

Cost-Effectiveness of a Tuberculosis Active Case Finding Program Targeting Household and Neighborhood Contacts in Cambodia
por: Yadav, Rajendra P., et al.
Publicado: (2014)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates
por: Portnoy, Allison, et al.
Publicado: (2020)

Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service Costs
por: Satyanarayana, Srinath, et al.
Publicado: (2023)

Economic evaluation of patient costs associated with tuberculosis diagnosis and care in Solomon Islands
por: Viney, Kerri, et al.
Publicado: (2021)

WHO-led consensus statement on vaccine delivery costing: process, methods, and findings
por: Levin, Ann, et al.
Publicado: (2022)

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
por: Postma, Maarten J, et al.
Publicado: (2011)

Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool)
por: Morgan, Winthrop, et al.
Publicado: (2020)

Costs of Illness Due to Cholera, Costs of Immunization and Cost-Effectiveness of an Oral Cholera Mass Vaccination Campaign in Zanzibar
por: Schaetti, Christian, et al.
Publicado: (2012)

Correction to: Economic evaluation of patient costs associated with tuberculosis diagnosis and care in Solomon Islands
por: Viney, Kerri, et al.
Publicado: (2021)

Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021–2030
por: Sriudomporn, Salin, et al.
Publicado: (2022)

Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries
por: Munk, Cristina, et al.
Publicado: (2019)

Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness
por: Procter, Simon R., et al.
Publicado: (2023)

Stability, cytotoxicity and cell uptake of water-soluble dendron–conjugated gold nanoparticles with 3, 12 and 17 nm cores
por: Deol, Suprit, et al.
Publicado: (2015)

Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
por: Xia, Changfa, et al.
Publicado: (2021)

Costs of delivering human papillomavirus vaccination in Tanzania
por: Struckmann, V, et al.
Publicado: (2022)

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector
por: Hutubessy, Raymond, et al.
Publicado: (2003)

Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines
por: Florentino, Jhiedon L., et al.
Publicado: (2022)

Cost–effectiveness thresholds: pros and cons
por: Bertram, Melanie Y, et al.
Publicado: (2016)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization
por: Jit, Mark, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hgmq03a2286qfehd7igkf7pou0